Filter News
Area of Research
- (-) Biology and Environment (13)
- (-) Nuclear Science and Technology (5)
- (-) Supercomputing (21)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Clean Energy (19)
- Computational Biology (1)
- Fusion and Fission (3)
- Isotopes (17)
- Materials (41)
- Materials for Computing (4)
- National Security (11)
- Neutron Science (35)
News Type
News Topics
- (-) Biomedical (15)
- (-) Composites (1)
- (-) Cybersecurity (2)
- (-) Isotopes (2)
- (-) Materials Science (12)
- (-) Mathematics (3)
- (-) Neutron Science (6)
- (-) Physics (5)
- (-) Space Exploration (2)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (4)
- Artificial Intelligence (23)
- Big Data (17)
- Bioenergy (26)
- Biology (43)
- Biotechnology (7)
- Buildings (2)
- Chemical Sciences (4)
- Clean Water (8)
- Climate Change (32)
- Computer Science (51)
- Coronavirus (10)
- Decarbonization (16)
- Energy Storage (2)
- Environment (65)
- Exascale Computing (14)
- Frontier (13)
- Fusion (6)
- Grid (1)
- High-Performance Computing (27)
- Hydropower (5)
- Machine Learning (9)
- Materials (5)
- Mercury (6)
- Microscopy (8)
- Molten Salt (1)
- Nanotechnology (7)
- National Security (4)
- Net Zero (2)
- Nuclear Energy (19)
- Polymers (1)
- Quantum Computing (10)
- Quantum Science (10)
- Renewable Energy (1)
- Security (1)
- Simulation (15)
- Software (1)
- Summit (23)
- Sustainable Energy (17)
- Transformational Challenge Reactor (2)
- Transportation (3)
Media Contacts
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Since the 1930s, scientists have been using particle accelerators to gain insights into the structure of matter and the laws of physics that govern our world.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
Radioactive isotopes power some of NASA’s best-known spacecraft. But predicting how radiation emitted from these isotopes might affect nearby materials is tricky
From materials science and earth system modeling to quantum information science and cybersecurity, experts in many fields run simulations and conduct experiments to collect the abundance of data necessary for scientific progress.
Scientists at the Department of Energy Manufacturing Demonstration Facility at ORNL have their eyes on the prize: the Transformational Challenge Reactor, or TCR, a microreactor built using 3D printing and other new approaches that will be up and running by 2023.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.
With Tennessee schools online for the rest of the school year, researchers at ORNL are making remote learning more engaging by “Zooming” into virtual classrooms to tell students about their science and their work at a national laboratory.
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s Oak Ridge National Laboratory are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.